Stock A036220 OSANG HEALTHCARE CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Osang Healthcare Co.,Ltd

Equities

A036220

KR7036220002

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-10 pm EDT 		5-day change 1st Jan Change
16,400 KRW -1.80% Intraday chart for Osang Healthcare Co.,Ltd +1.80% +368.57%
Jun. 17 Osang Healthcare Co.,Ltd announces an Equity Buyback for 375,657 shares. CI
Jun. 17 Osang Healthcare Co.,Ltd authorizes a Buyback Plan. CI

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 34,879 34,879 34,879 34,879
Enterprise Value (EV) 1 -32,250 -11,705 -25,549 -108,157
P/E ratio 0.36 x 29.5 x 1.1 x 0.39 x
Yield 57.1% 28.6% 85.7% 57.1%
Capitalization / Revenue 0.14 x 0.26 x 0.18 x 0.1 x
EV / Revenue -0.13 x -0.09 x -0.13 x -0.3 x
EV / EBITDA -0.2 x 3.72 x -0.47 x -0.73 x
EV / FCF - -1,551,955 x -736,526 x -1,152,159 x
FCF Yield - -0% -0% -0%
Price to Book 0.22 x 0.24 x 0.22 x 0.15 x
Nbr of stocks (in thousands) 9,965 9,965 9,965 9,965
Reference price 2 3,500 3,500 3,500 3,500
Announcement Date 3/30/22 3/30/22 3/31/23 3/21/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales 1 257,967 132,327 193,893 355,847
EBITDA 1 163,354 -3,150 54,668 148,675
EBIT 1 160,680 -7,106 49,255 142,339
Operating Margin 62.29% -5.37% 25.4% 40%
Earnings before Tax (EBT) 1 155,356 38.06 51,840 152,435
Net income 1 124,996 1,460 40,647 116,436
Net margin 48.45% 1.1% 20.96% 32.72%
EPS 2 9,610 118.7 3,168 8,921
Free Cash Flow - 7,542 34,689 93,874
FCF margin - 5.7% 17.89% 26.38%
FCF Conversion (EBITDA) - - 63.45% 63.14%
FCF Conversion (Net income) - 516.44% 85.34% 80.62%
Dividend per Share 2 2,000 1,000 3,000 2,000
Announcement Date 3/30/22 3/30/22 3/31/23 3/21/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt 1 - - - -
Net Cash position 1 67,129 46,584 60,428 143,036
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - 7,542 34,689 93,874
ROE (net income / shareholders' equity) - 0.78% 21.5% 47.3%
ROA (Net income/ Total Assets) - -2.05% 14% 31.2%
Assets 1 - -71,369 289,531 372,839
Book Value Per Share 2 16,148 14,488 15,768 23,285
Cash Flow per Share 2 5,617 3,824 3,009 8,710
Capex 1 7,822 9,040 11,702 35,703
Capex / Sales 3.03% 6.83% 6.04% 10.03%
Announcement Date 3/30/22 3/30/22 3/31/23 3/21/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Diagnostic & Testing Substances

1st Jan change Capi.
OSANG HEALTHCARE CO.,LTD Stock Osang Healthcare Co.,Ltd
+368.57% 169M
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+99.39% 7.36B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-21.23% 6.62B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+7.89% 5.73B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-22.19% 3.46B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.24% 2.5B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+35.32% 2.28B
VITROLIFE AB Stock Vitrolife AB
-7.91% 2.22B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-69.64% 1.88B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-18.50% 1.57B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. A036220 Stock
  4. Financials Osang Healthcare Co.,Ltd